An Open Label Study for Participants With Rheumatoid Arthritis

NCT01215942 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1086

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient efficacy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LY2127399

Sponsor

Eli Lilly and Company